Published in Volume
78, Issue 3 (September 1986)
J Clin Invest. 1986;78(3):666–673.
doi:10.1172/JCI112625.
Copyright ©
1986, The American Society for
Clinical Investigation.
Research Article
In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells.
N L Letvin, L V Chalifoux, K A Reimann, J Ritz, S F Schlossman and J M Lambert
Published September 1986
The selective delivery in vivo of a T lymphocyte-specific monoclonal antibody and immunotoxin conjugates to T cells in lymph node and spleen was assessed in rhesus monkeys. A transient coating of all T lymphocytes in the lymph nodes and spleens of healthy rhesus monkeys could be achieved after infusion of unconjugated anti-T11. Because derivatized antibody is cleared more rapidly than unconjugated antibody, it was necessary to infuse a higher dose of immunotoxin than antibody alone to achieve saturation of the lymphocyte binding sites with anti-T11. When sufficient antibody-toxin conjugate was infused, toxin was readily demonstrable on lymph node and spleen T cells by 16 h after infusion. This demonstration that toxins can be successfully delivered with specificity to target T cell populations in the monkey suggests that killing of restricted cell populations in vivo should be feasible.
Browse pages
Click on an image below to see the page. View
PDF of the complete article